Results 201 to 210 of about 147,278 (254)
Afatinib and osimertinib showed broadly comparable survival outcomes as first‐line therapy for NSCLC with uncommon EGFR mutations. Treatment may be individualized by mutation subtype, while adding immune checkpoint inhibition to platinum doublet after EGFR‐TKI showed no clear benefit.
Yutaro Nagano +21 more
wiley +1 more source
Multimodality Imaging of a Pulmonary Valve Papillary Fibroelastoma Associated With Pulmonary Embolism. [PDF]
Tejada C +5 more
europepmc +1 more source
Short‐Term Complications Are Rare After Cholesteatoma Surgery
ABSTRACT Objective To evaluate the incidence and nature of short‐term complications following cholesteatoma surgery in a heterogeneous cohort. Design A retrospective cohort study including complete coverage of cholesteatoma surgery in a Swedish region between 1 January 2005 and 31 December 2015.
Agnes Modée Borgström +3 more
wiley +1 more source
STORM-PE: early right ventricular unloading in intermediate-high risk pulmonary embolism. [PDF]
Saleh H, Amil F, Domaleski L.
europepmc +1 more source
Correction: Acute pulmonary embolism: a paradigm shift in interventional treatment and interdisciplinary care? [PDF]
Lüdemann WM +5 more
europepmc +1 more source
Primary Pulmonary Artery Sarcoma: Multimodality Imaging of a Rare Intravascular Tumor Mimicking Pulmonary Embolism. [PDF]
Li D, Liu Z, Liang S, Zhang H.
europepmc +1 more source
Case Report: Early management and successful thrombolysis in two cases of high-risk pulmonary embolism. [PDF]
Zhang Y +6 more
europepmc +1 more source
A Challenging Pulmonary Embolism: When Acute Meets Chronic Thrombus. [PDF]
Lee JCY +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:

